Chronic sparing of delayed alternation performance and choline acetyltransferase activity by CEP-1347/KT-7515 in rats with lesions of nucleus basalis magnocellularis

Neuroscience

Volumn 86, Issue 2, 1998, Pages 473-483

  DiCamillo, A M ^a   Neff, N T ^a   Carswell, S ^a   Haun, F A ^a  

^a CEPHALON INC   (United States)

Author keywords

Alzheimer's disease; Attention; Cholinergic; Perseveration; T maze

Indexed keywords

CARBAZOLE DERIVATIVE; CEP 1347; CHOLINE ACETYLTRANSFERASE; IBOTENIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION; CONTROLLED STUDY; ENZYME ACTIVITY; MAGNOCELLULAR NUCLEUS; MALE; MAZE TEST; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TASK PERFORMANCE;

ANIMALS; CARBAZOLES; CHOLINE O-ACETYLTRANSFERASE; ENZYME INHIBITORS; FRONTAL LOBE; FUNCTIONAL LATERALITY; IBOTENIC ACID; INDOLES; MALE; MAZE LEARNING; MEMORY; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SUBSTANTIA INNOMINATA; TIME FACTORS;

EID: 0032100674     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00060-8     Document Type: Article

References (74)

1. Benninger R. J., Kuhnemann S., Ingles J. L., Jhamandas K., Boegman R. J. Mnemonic deficits in the double Y-maze are related to the effects of nucleus basalis injections of ibotenic and quisqualic acid on choline acetyltransferase in the rat amygdala. Brain Res. Bull. 35:1994;147-152.
2. Butt A. E., Hodge G. K. Acquisition, retention, and extinction of operant discriminations in rats with nucleus basalis magnocellularis lesions. Behav. Neurosci. 109:1995;699-713.
3. 1. Acta neurobiol. exp. 50:1990;461-473.
4. Connor D. J., Langdon D. J., Langlais P. J., Thal L. J. Effects of NBm lesions on T-maze performance and thalamic biochemistry. Neurobiol. Aging. 14:1993;535-537.
5. Cullen M., Baker M., Pelleymounter M. Glial-derived neurotrophic factor (GDNF) improves spatial learning in aged Fischer 344 and Long-Evans rats. Soc. Neurosci. Abstr. 22:1996;1952.
6. Decker M. W., Curzon P., Brioni J. D., Arnerie S. P. Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. Eur. J. Pharmac. 261:1994;217-222.
7. Dekker A. J. A. M., Connor D. J., Thal L. J. The role of cholinergic projections from the nucleus basalis in memory. Neurosci. Biobehav. Rev. 15:1991;299-317.
8. Dekker A. J., Gage F. H., Thal L. J. Delayed treatment with nerve growth factor improves acquisition of a spatial task in rats with lesions of the nucleus basalis magnocellularis: evaluation of the involvement of different neurotransmitter systems. Neuroscience. 48:1992;111-119.
9. Dekker A. J., Fagan A. M., Gage F. H., Thal L. J. Effects of brain-derived neurotrophic factor and nerve growth factor on remaining neurons in the lesioned nucleus basalis magnocellularis. Brain Res. 639:1994;149-155.
10. Dekker A. J., Winkler J., Ray J., Thal L. J., Gage F. H. Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of nucleus basalis magnocellularis. Neuroscience. 60:1994;299-309.
11. Dember W. N., Fowler H. Spontaneous alternation behaviour. Psychol. Bull. 55:1958;412-428.
12. Divac I., Wikmark R. G. E., Gade A. Spontaneous alternation in rats with lesions in the frontal lobes. Physiol. Psychol. 3:1975;39-42.
13. Dornan W. A., McCampbell A. R., Tinkler G. P., Hickman L. J., Bannon A. W., Decker M. W., Gunther K. L. Comparison of site-specific injections into the basal forebrain on water maze and radial arm maze performance in the male rat after immunolesioning with 192 IgG saporin. Behav. Brain Res. 82:1996;93-101.
14. Dunnett S. B., Whishaw I. Q., Jones G. H., Bunch S. T. Behavioural, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neuroscience. 20:1987;653-669.
15. Dunnett S. B., Rogers D. C., Jones G. H. Effects of nucleus basalis magnocellularis lesions in rats on delayed matching and non-matching to position tasks: disruption of conditional discrimination learning but not of short-term memory. Eur. J. Neurosci. 1:1989;395-406.
16. Dunnett S. B., Everitt B. J., Robbins T. W. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 14:1991;494-500.
17. Eagleson K. L., Cunningham T. J., Haun F. Rescue of both rapidly and slowly degenerating neurons in the dorsal lateral geniculate nucleus of adult rats by a cortically derived neuron survival factor. Expl Neurol. 116:1992;156-162.
18. Gash D. M., Zhang Z., Ovadia A., Cass W. A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P. A., Collin F., Hoffer B. J., Gerhardt G. A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255.
19. Glicksman M. A., Prantner J. E., Meyer S. L., Forbes M. E., Dasgupta M., Lewis M. E., Neff N. T. K-252a and staurosporine promote choline acetyltransferase activity in rat spinal cord cultures. J. Neurochem. 61:1993;210-221.
20. Glicksman M. A., Forbes M. E., Pranter J. E., Neff N. T. K-252a promotes survival and choline acetyltransferase activity in striatal and basal forebrain neuronal cultures. J. Neurochem. 64:1995;1502-1512.
21. Glicksman M. A., Chiu A. Y., Dionne C. A., Harty M., Kaneko M., Matsuda Y., Murakata C., Oppenheim R. W., Prevette D., Sengelaub M., Vaught J. L. and Neff N. T. (1997) CEP-1347/KT-7515 prevents motoneuronal programmed cell death and injury-induced de-differentiation in vivo. (Submitted).
22. Haroutunian V., Kanof P. D., Davis K. L. Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor. Brain Res. 386:1986;397-399.
23. Haroutunian V., Kanof P. D., Davis K. L. Attenuation of nucleus basalis of Meynert lesion-induced cholinergic deficits by nerve growth factor. Brain Res. 487:1989;200-203.
24. Haun F., Cunningham T. J. Recovery of frontal cortex-mediated visual behaviors following neurotrophic rescue of axotomized neurons in medial frontal cortex. J. Neurosci. 13:1993;614-622.
25. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6:1986;2155-2162.
26. Hepler D. J., Olton D. S., Wenk G. L., Coyle J. T. Lesions in nucleus basalis magnocellularis and medial septal area of rats produce qualitatively similar memory impairments. J. Neurosci. 5:1985;866-873.
27. Hepler D. J., Wenk G. L., Cribbs B. L., Olton D. S., Coyle J. T. Memory impairments following basal forebrain lesions. Brain Res. 346:1985;8-14.
28. Iraizoz I., de Lacalle S., Gonzalo L. M. Cell loss and nuclear hypertrophy in topographical subdivisions of the nucleus basalis of Meynert in Alzheimer's disease. Neuroscience. 41:1991;33-40.
29. Kaneko M., Saito Y., Saito H., Matsumoto T., Matsuda Y., Vaught J. L., Dionne C. A., Angeles T. A., Glicksman M. A., Neff N. T., Rotella D. P., Kauer J. C., Mallamo J. P., Hudkins R. L. and Murakata C. (1997) Neurotrophic 3,9-alkylthiomethyl- and alkoxymethyl-K-252a derivatives. J. med. Chem., (in press).
30. Koliatsos V. E., Price D. L., Gouras G. K., Cayouette M. H., Burton L. E., Winslow J. W. Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons. J. comp. Neurol. 262:1994;247-262.
31. Kwo-On-Yuen P. F., Mandel R., Chen A. D., Thal L. J. Tetrahydroaminoacridine improves the spatial acquisition deficit produced by nucleus basalis lesions in rats. Expl Neurol. 108:1990;221-228.
32. Langlais P. J., Connor D. J., Thal L. Comparison of the effects of single and combined neurotoxic lesions of the nucleus basalis magnocellularis and dorsal noradrenergic bundle on learning and memory in the rat. Behav. Brain Res. 54:1993;81-90.
33. Liberini P., Pioro E. P., Maysinger D., Ervin F. R., Cuello A. C. Long-term protective effects of human recombinant nerve growth factor and monosialoganglioside GM1 treatment on primate nucleus basalis cholinergic neurons after neocortical infarction. Neuroscience. 53:1993;625-637.
34. Mallet P. E., Beninger R. J., Flesher S. N., Jhamandas K., Boegman R. J. Nucleus basalis lesions: implication of basoamygdaloid cholinergic pathways in memory. Brain Res. Bull. 36:1995;51-56.
35. Mandel R. J., Gage F. H., Thal L. J. Spatial learning in rats: correlation with cortical choline acetyltransferase and improvement with NGF following NBM damage. Expl Neurol. 104:1989;208-217.
36. McGaughy J., Kaiser T., Sarter M. Behavioral vigilance following infusions of 192IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav. Neurosci. 110:1996;247-265.
37. Montero C. N., Hefti F. Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment. J. Neurosci. 8:1988;2986-2999.
38. Muir J. L., Dunnett S. B., Robbins T. W., Everitt B. J. Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Expl Brain Res. 89:1992;611-622.
39. Muir J. L., Everitt B. J., Robbins T. W. AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J. Neurosci. 14:1994;2313-2326.
40. Muir J. L., Everitt B. J., Robbins T. W. The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cerebral Cortex. 6:1996;470-481.
41. Murray C. L., Fibiger H. C. Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine. Neuroscience. 14:1985;1025-1032.
42. Nakamura S., Nakagawa Y., Kawai M., Tohyama M., Ishihara T. AF64A (ethylcholine aziridinium ion)-induced basal forebrain lesion impairs maze performance. Behav. Brain Res. 29:1988;119-126.
43. Naumann T., Kermer P., Seydewitz V., Ortmann R., D'Amato F., Frotscher M. Is there a long-lasting effect of short-term nerve growth factor application on axotomized rat septohippocampal neurons? Neurosci. Lett. 173:1994;213-215.
44. Nelson H. E. A modified card sorting test sensitive to frontal lobe defects. Cortex. 12:1976;313-324.
45. Nitta A., Murakami Y., Furukawa Y., Kawatsura W., Hayashi K., Yamada K., Hasegawa T., Nabeshima T. Oral administration of idebenone induces nerve growth factor in the brain and improves learning and memory in basal forebrain-lesioned rats. Naunyn-Schmiedeberg's Arch. Pharmac. 407:1994;349-401.
46. Page K. J., Everitt B. J., Robbins T. W., Marston H. M., Wilkinson L. S. Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss. Neuroscience. 43:1991;457-472.
47. Pallage V., Ornstein D., Will B. Nerve growth factor and septal grafts: a study of behavioral recovery following partial damage to the septum in rats. Behav. Brain Res. 47:1992;1-12.
48. Pallage V., Knusel B., Hefti F., Will B. Functional consequences of single nerve growth factor administration following septal damage in rats. Eur. J. Neurosci. 5:1993;669-679.
49. Pang K., Williams M. J., Egeth H., Olton D. S. Nucleus basalis magnocellularis and attention: effects of muscimol infusions. Behav. Neurosci. 107:1993;1031-1038.
50. Parasuraman R., Haxby J. V. Attention and brain function in Alzheimer's disease: a review. Neuropsychology. 7:1993;242-272.
51. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic, San Diego.
52. Peternel A., Hughey D., Wenk G., Olton D. Basal forebrain and memory: neurotoxic lesions impair serial reversals of a spatial discrimination. Psychobiology. 16:1988;54-58.
53. Porsolt R. D., Roux S., Wettstein J. G. Animal models of dementia. Drug Dev. Res. 35:1995;214-229.
54. Rinne J. O., Palijarvi L., Rinne U. K. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease. J. neurol. Sci. 79:1987;67-76.
55. Sahakian B. J., Owen A. M., Morant N. J., Eagger S. A., Boddington S., Crayton L., Crockford H. A., Crooks M., Hill K., Levy R. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology. 110:1993;395-401.
56. Salamone J. D., Beart P. M., Alpert J. E., Iversen S. D. Impairment in T-maze reinforced alternation performance following nucleus basalis magnocellularis lesions in rats. Behav. Brain Res. 13:1984;63-70.
57. Saporito M. S., Brown E. R., Carswell S., DiCamillo A. M., Miller M. S., Murakata C., Neff N. T., Vaught J. L. and Haun F. (1997) Preservation of cholinergic activity and prevention of neuron death by CEP-1347/KT-7515 following excitotoxic injury of the nucleus basalis magnocellularis. (Submitted).
58. Sauer H., Rosenblad C., Bjorklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor B3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. natn. Acad. Sci. U.S.A. 92:1995;8935-8939.
59. Sinden J. D., Allen Y. S., Rawlins J. N. P., Gray J. A. The effects of ibotenic acid lesions of the nucleus basalis and cholinergic-rich neural transplants on win-stay/lose-shift and win-shift/lose-stay performance in the rat. Behav. Brain Res. 36:1990;229-249.
60. Tierney M. C., Szalai J. P., Snow W. G., Fisher R. H., Nores A., Nadon G., Dunn E., St George-Hyslop P. H. Prediction of probable Alzheimer's disease in memory-impaired patients. Neurology. 46:1996;661-665.
61. Torres E. M., Perry T. A., Blokland A., Wilkinson L. S., Wiley R. G., Lappi D. A., Dunnett S. B. Behavioral, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience. 63:1994;95-122.
62. Tuszynski M. H., Gage F. H. Bridging grafts and transient nerve growth factor infusions promote long-term central nervous system neuronal rescue and partial functional recovery. Proc. natn. Acad. Sci. U.S.A. 92:1995;4621-4625.
63. Tuszynski M. H., Buzsaki G., Gage F. H. Nerve growth factor infusions combined with fetal hippocampal grafts enhance reconstruction of the lesioned septohippocampal projection. Neuroscience. 36:1990;33-44.
64. Vargo J. M., Corwin J. V., King V., Reep R. L. Hemispheric asymmetry in neglect produced by unilateral lesions of dorsomedial prefrontal cortex in rats. Expl Neurol. 102:1988;199-209.
65. Verfaellie M., Heilman K. M. Response preparation and response inhibition after lesions of the medial frontal lobe. Archs Neurol. 44:1987;1265-1271.
66. Vogels O. J. M., Broere C. A. J., Ter Laak H. J., Ten Donkelaar H. J., Nieuwenhuys R., Schulte B. P. M. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol. Aging. 11:1990;3-13.
67. Voytko M. L., Olton D. S., Richardson R. T., Gorman L. K., Tobin J. R., Price D. L. Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J. Neurosci. 14:1994;167-186.
68. Wenk G. L., Harrington C. A., Tucker D. A., Rance N., Walker L. C. Basal forebrain neurons and memory: a biochemical, histological, and behavioral study of differential vulnerability to ibotenate and quisqualate. Behav. Neurosci. 106:1992;909-923.
69. Wenk G. L., Danysz W., Mobley S. L. Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat. Brain Res. 655:1994;7-11.
70. Wenk G. L., Stoehr J. D., Quintana G., Mobley S., Wiley R. G. Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J. Neurosci. 14:1994;5986-5995.
71. Wenk G. L., Stoehr J. D., Mobley S. L., Gurney J., Morris R. J. Age-related decrease in vulnerability to excitatory amino acids in the nucleus basalis. Neurobiol. Aging. 17:1996;1-7.
72. White S. R. Atropine, scopolamine and hippocampal lesion effects on alternation performance of rats. Pharmac. Biochem. Behav. 2:1974;297-307.
73. Will B., Hefti F. Behavioural and neurochemical effects of chronic intraventricular injection of nerve growth factor in adult rats with fimbria lesions. Behav. Brain Res. 17:1985;17-24.
74. Winkler J., Thal L. J. Effects of nerve growth factor treatment on rats with lesions of the nucleus basalis magnocellularis produced by ibotenic acid, quisqualic acid, and AMPA. Expl Neurol. 136:1995;234-250.